How many vials of macituximab/magenex are needed for one course of treatment?

Margetuximab is a HER2-targeting monoclonal antibody drug, and its administration method and dosage are strictly regulated. Patients and their families are often concerned about how many pills are needed for a complete breast cancer treatment course. This is not only related to treatment planning, but also directly affects the economic burden. According to the recommended instructions, the dose of margetuximab is 15mg/kg, which should be administered intravenously every 3 weeks (21-day cycle) until the disease progresses or the patient develops intolerable adverse reactions. The initial dose requires an infusion within 120 minutes, while subsequent doses can usually be completed within at least 30 minutes.

Based on common packaging specifications250mg/bottle, the amount of medicine required for a course of treatment depends on the patient's weight. For example, a patient weighing 60kg requires approximately 900mg of dose each time, and would need to use 4 bottles (250mg/bottle) to meet one dosing cycle. Patients with higher body weight, such as those above 70kg, will require more bottles per cycle. In other words, the number of drugs required in a course of treatment is directly linked to the individual's weight, and there is no uniform fixed amount. Since margetuximab is a continuous medication, the treatment course is not a preset fixed period, but is continued according to the disease control status until the efficacy is insufficient or serious side effects occur.

Additionally, in some patients, margetuximab is given in combination with chemotherapy. Clinical practice is usually to continue margetuximab immediately after completion of chemotherapy administration to enhance the overall therapeutic effect. In this case, the number of margituximab tubes is still determined based on body weight and dose, and the dose will not be reduced due to combined use. When family members consult about the number of bottles required for a course of treatment, they should clarify their individual characteristics, and the doctor will make a comprehensive judgment based on the patient's weight and disease progression.

Reference materials:https://www.margenza.com/